The Orthopaedic Shock Wave Therapy in the Treatment of Chronic Insertion Tendopathy and Tendinosis Calcarea

Haist, J; Keitz-Steeger, D. von; Mohr, Gerhard J.; Schulze, G; Weber, Federico Leopoldo Rodríguez

doi:10.1007/978-3-642-80427-4_9

Cited by 3 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, only 24 articles describing 1,585 patients (33%) satisfied their standards of an adequate scientific evaluation and only 978 (20%) involved their Type A or B study classification. Haist et al 22 and Haupt" reviewed the emerging musculoskeletal applications of extracorporeal shockwaves. Both articles supported the apparent positive results from shockwave therapy, while stressing the need for additional clinical outcome studies.…”

Section: Discussionmentioning

confidence: 99%

“…20 The technology has been used in Europe for approximately 10 years for the treatment of numerous muscu loskeletal cond itions. 4,10-14, 18,19,[22][23][24][25][26][27][28]31,36,46,[52][53][54][55][56][57][58]63,71 The emphasis has been on clinical applications, without a great deal of experimental evaluation of the specific mechanisms of shockwave action on different musculoskeletal tissues or contiguous neurovascular structures. Many of the published clinical studies lack significant data generation parameters that would allow credible outcome analysis.…”

Section: Table 1: Outcome Study Selection Criteriamentioning

confidence: 99%

See 1 more Smart Citation

Shockwave Therapy for Chronic Proximal Plantar Fasciitis: A Meta-Analysis

Ogden

Alvarez

Marlow³

2002

Foot Ankle Int.

113

View full text Add to dashboard Cite

This meta-analysis shows that the directed application of shockwaves to the enthesis of the plantar fascia at the inferior calcaneus is a safe and effective nonsurgical method for treating chronic, recalcitrant heel pain syndrome that has been refractory to other commonly used nonoperative therapies. The results suggest that this therapeutic procedure should be considered before any surgical intervention, and may be preferable prior to cortisone injection, which has a recognized risk of rupture of the plantar fascia and a frequent recurrence of symptoms.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Table 1: Outcome Study Selection Criteriamentioning

confidence: 99%

Shockwave Therapy for Chronic Proximal Plantar Fasciitis: A Meta-Analysis

Ogden

Alvarez

Marlow³

2002

Foot Ankle Int.

113

View full text Add to dashboard Cite

show abstract

“…In Germany, where the therapy was developed, over 65 000 treatments using ESWT are given annually for musculoskeletal complaints. [1][2][3][4][5] The rationales proposed for the use of the technique in such conditions include the promotion of soft-tissue healing, 7 reduction of calcification, 4 inhibition of pain receptors 6 or denervation to achieve relief from pain. 5 In spite of the enthusiasm for its use in musculoskeletal conditions there has been no randomised, controlled trial to evaluate the effect of ESWT in specific conditions.…”

Section: Discussionmentioning

confidence: 99%

“…[1][2][3][4][5] The theoretical benefits are the stimulation of tissue healing and the breakdown of calcification. [4][5][6][7] In spite of the increasing popularity of this method of treatment, there has been no randomised, controlled trial of its use in specific musculoskeletal conditions. Benefit from ESWT has been demonstrated in calcific tendonitis of the rotator cuff.…”

mentioning

confidence: 99%

Extracorporeal shock-wave therapy for tendonitis of the rotator cuff: A double-blind, randomised, controlled trial

Speed¹,

Richards²,

Nichols³

et al. 2002

The Journal of Bone and Joint Surgery

View full text Add to dashboard Cite

We have performed a double-blind placebo-controlled trial of moderate doses of extracorporeal shock-wave therapy (ESWT) for non-calcific tendonitis of the rotator cuff. Adults (74) with chronic tendonitis of the rotator cuff were randomised to receive either active (1500 pulses ESWT at 0.12 mJ/mm2) or sham treatment, monthly for three months. All were assessed before each treatment, and at one and three months after the completion of treatment. The outcome was measured with regard to pain in the shoulder, including a visual analogue score for night pain, and a disability index. There were no significant differences between the two groups before treatment. The mean duration of symptoms in both groups was 23.3 months. Both showed significant and sustained improvements from two months onwards. There was no significant difference between them with respect to change in the Shoulder Pain and Disability Index (SPADI) scores or night pain over the six-month period. A mean (+/-SD; range) change in SPADI of 16.1 +/- 27.2 (0 to 82) in the treatment group and 24.3 +/- 24.8 (-11 to 83) in the sham group was noted at three months. At six months the mean changes were 28.4 +/- 25.9 (-24 to 69) and 30.4 +/- 31.2 (-12 to 88), respectively. Similar results were noted for night pain. We conclude that there is a significant and sustained placebo effect after moderate doses of ESWT in patients with non-calcific tendonitis of the rotator cuff, but there is no evidence of added benefit when compared with sham treatment.

show abstract